Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07173205

Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit

R00 Full Factorial Trial: Optimizing ASCENT

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
208 (estimated)
Sponsor
East Carolina University · Academic / Other
Sex
All
Age
15 Years – 39 Years
Healthy volunteers
Not accepted

Summary

Our team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes one psychoeducation component and four components that are based on evidence-based interventions for depression. The goal of this study is to test which component or combination of components meaningfully contribute to improvements in depressive symptoms among AYAs.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAYA Survivors Coping and Emotional Needs Toolkit (ASCENT)Participants will receive access to a digital depression self-management tool (ASCENT), which aims to help AYAs manage symptoms of depression post-treatment. All users will have access to the core tool which includes daily mood tracking and a psychoeducational module about cancer and depression. Depending on assigned condition, participants will also receive access to up to 4 intervention modules which have been adapted from existing evidence-based treatments for digital delivery to AYAs through a rigorous user-centered design process. Within each module there are 6 micro-lessons that include an educational video, a real story from an AYA that demonstrates the topic, multiple choice questions that ask the participant to apply the educational information to the AYA story, open-ended questions that ask the participant to apply the educational information to their own experience, and a practice activity in which they are asked to try out a relevant skill.

Timeline

Start date
2025-10-25
Primary completion
2026-12-01
Completion
2027-03-01
First posted
2025-09-15
Last updated
2026-01-07

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07173205. Inclusion in this directory is not an endorsement.